(175 days)
Not Found
No
The document describes a surgical system and a thermal insulation pad, focusing on their physical properties and intended use for tissue coagulation and insulation. There is no mention of AI, ML, image processing, or data-driven decision-making within the device's functionality.
Yes
The device is described as "intended for the coagulation of cardiac tissue using radiofrequency (RF) energy during cardiac surgery" and also for "coagulat[ing] blood and soft tissue to produce hemostasis," which are therapeutic actions.
No
The device description and intended use focus on coagulation and thermal insulation during surgery, which are therapeutic functions, not diagnostic ones. There is no mention of identifying or detecting medical conditions.
No
The device description clearly describes a physical silicone pad (ThermaShield) and its intended use as a thermal insulator during surgical procedures, indicating it is a hardware component of a surgical system.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use is for the coagulation of cardiac and soft tissues using radiofrequency energy during surgery. This is a therapeutic procedure performed directly on the patient's body.
- Device Description: The device is a surgical system and a thermal insulator used during surgery. It is not designed to analyze samples taken from the body (like blood, urine, or tissue samples) to diagnose a condition.
- Lack of IVD Characteristics: The description does not mention any analysis of biological samples, diagnostic purposes, or laboratory use, which are hallmarks of IVD devices.
IVD devices are used in vitro (outside the body) to examine specimens from the human body to provide information for diagnostic, monitoring, or compatibility purposes. This device is used in vivo (inside the body) for a therapeutic purpose (coagulation).
N/A
Intended Use / Indications for Use
The Estech Cobra Surgical System is intended for the coagulation of cardiac tissue using radiofrequency (RF) energy during cardiac surgery. The System can be used during general surgery to coagulate soft tissues. The System may also be used to coagulate blood and soft tissue to produce hemostasis.
Product codes (comma separated list FDA assigned to the subject device)
OCL
Device Description
The ThermaShield is a flat, bell-shaped silicone pad that is designed to reliably fill the anatomic space between the target tissue of an RF ablation and adjacent non-target tissue. Its thickness and rounded edges provide tactile feedback to the surgeon and facilitates confidence in proper placement. The ThermaShield is primarily designed for use in open chest cardiac surgery.
The addition of the ThermaShield to the ESTECH Cobra Surgical System provides a more convenient option for the physician to thermally insulate surrounding non-target tissue during RF ablations. The ThermaShield is intended to improve upon circumstances where no insulation is used or to replace the current use of a surgical glove as a thermal insulator between target and surrounding tissues (Williams, 2004; article in TAB 5).
The application ESTECH Cobra Surgical System with ThermaShield Accessory is identical in nearly every way to the predicate device, the ESTECH Cobra Surgical System (K051749). The only difference between the two systems is that this application requests clearance for the addition of a thermal insulation pad, known as the ThermaShield.
This SPECIAL 510(k) is being submitted only to accommodate the inclusion of the ThermaShield. Estech is not requesting any change to the Indications for Use of the ESTECH Cobra Surgical System, nor are there any technological changes being submitted for the ESTECH Cobra Surgical System.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
cardiac tissue, soft tissues
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Bench data provided in Section 18 demonstrates that the ThermaShield performs as intended and does not raise new types of safety or efficacy questions.
Bench testing supplied in Section 18 demonstrates that the ThermaShield technology is equivalent or better than surgical gloves, commonly used clinically, in thermally insulating adjacent tissues and is an improvement over having no insulation of surrounding tissues during ablation with the previously cleared COBRA Surgical System.
The patient contacting materials of the ESTECH ThermaShield technology have been demonstrated to be biocompatible, in accordance with ISO 10993: Biological Evaluation of Medical Devices, and the safety of the electrical design is in conformance with the pertinent sections of IEC 60601-1-2, (Second Edition, 2001), Medical Electrical Equipment - Part 1-2: General Requirements for Safety - Collateral Standard: Electromagnetic Compatibility -- Requirements and Tests and IEC 60601-2-2: Medical electrical equipment - Part 2-2: Particular requirements for the safety of high frequency surgical equipment.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 878.4400 Electrosurgical cutting and coagulation device and accessories.
(a)
Identification. An electrosurgical cutting and coagulation device and accessories is a device intended to remove tissue and control bleeding by use of high-frequency electrical current.(b)
Classification. Class II.
0
Image /page/0/Picture/0 description: The image shows the logo for "estech". The logo consists of a circular icon to the left of the word "estech". The icon contains three horizontal lines inside of a circle. The word "estech" is written in a simple, sans-serif font.
K 440913 SEP 2 3 2011
Section 5: Special 510(k) SUMMARY OF SAFETY AND EFFECTIVENESS
| Device Information: | |
|---|---|
| Category | Comments |
| Sponsor: | ESTECH, Inc. |
| 2603 Camino Ramon | |
| Suite 100 | |
| San Ramon, CA 94583 | |
| Tel: 925-543-2110 | |
| Correspondent: | Tamer Ibrahim |
| Vice President | |
| ESTECH, Inc | |
| Contact Information: | Tel: 925-543-2110 |
| Fax: 925-866-7117 | |
| Device Common Name: | Electrosurgical cutting and coagulation |
| device and accessories | |
| Device Proprietary Name: | ESTECH Cobra Surgical System with |
| ThermaShield accessory | |
| Device Classification: | Class II, OCL (21 CFR 878.4400) |
Predicate Device Information:
| Predicate Devices: | ESTECH Cobra Surgical System (K051749) |
|---|---|
| Predicate Device Manufacturers: | Endoscopic Technologies, Inc (aka |
| ESTECH) | |
| Predicate Device Common Name: | Electrosurgical cutting and coagulation |
| device and accessories | |
| Predicate Device Classification: | 21 CFR 878.4400 |
| Predicate Device Classification Number: | Class II, OCL |
b. Date Summary Prepared
31 March 2011
c. Description of Device
The ThermaShield is a flat, bell-shaped silicone pad that is designed to reliably fill the anatomic space between the target tissue of an RF ablation and adjacent non-target tissue. Its thickness and rounded edges provide tactile feedback to the surgeon and facilitates confidence in proper placement. The ThermaShield is primarily designed for use in open chest cardiac surgery.
The addition of the ThermaShield to the ESTECH Cobra Surgical System provides a more convenient option for the physician to thermally insulate surrounding non-target tissue during RF ablations. The ThermaShield is intended to improve upon
1
Image /page/1/Picture/0 description: The image shows the logo for "estech". The logo consists of a circular graphic to the left of the word "estech". The circular graphic contains three white, curved shapes inside a gray circle. The word "estech" is written in a simple, sans-serif font.
circumstances where no insulation is used or to replace the current use of a surgical glove as a thermal insulator between target and surrounding tissues (Williams, 2004; article in TAB 5).
d. Intended Use
The Estech Cobra Surgical System is intended for the coagulation of cardiac tissue using radiofrequency (RF) energy during cardiac surgery. The System can be used during general surgery to coagulate soft tissues. The System may also be used to coagulate blood and soft tissue to produce hemostasis.
e. Comparison to Predicate Device
The application ESTECH Cobra Surgical System with ThermaShield Accessory is identical in nearly every way to the predicate device, the ESTECH Cobra Surgical System (K051749). The only difference between the two systems is that this application requests clearance for the addition of a thermal insulation pad, known as the ThermaShield.
This SPECIAL 510(k) is being submitted only to accommodate the inclusion of the ThermaShield. Estech is not requesting any change to the Indications for Use of the ESTECH Cobra Surgical System, nor are there any technological changes being submitted for the ESTECH Cobra Surgical System.
Bench data provided in Section 18 demonstrates that the ThermaShield performs as intended and does not raise new types of safety or efficacy questions.
ESTECH concludes that the ESTECH Cobra Surgical System with ThermaShield accessory is substantially equivalent to the predicate ESTECH Cobra Surgical System.
f. Summary of Supporting Data
The bench testing supplied in Section 18 demonstrates that the ThermaShield technology is equivalent or better than surgical gloves, commonly used clinically, in thermally insulating adjacent tissues and is an improvement over having no insulation of surrounding tissues during ablation with the previously cleared COBRA Surgical System.
The patient contacting materials of the ESTECH ThermaShield technology have been demonstrated to be biocompatible, in accordance with ISO 10993: Biological Evaluation of Medical Devices, and the safety of the electrical design is in conformance with the pertinent sections of IEC 60601-1-2, (Second Edition, 2001), Medical Electrical Equipment - Part 1-2: General Requirements for Safety - Collateral Standard: Electromagnetic Compatibility -- Requirements and Tests and IEC 60601-2-2: Medical electrical equipment - Part 2-2: Particular requirements for the safety of high frequency surgical equipment.
2
DEPARTMENT OF HEALTH & HUMAN SERVICES
Image /page/2/Picture/1 description: The image shows the seal of the Department of Health and Human Services (HHS) of the United States. The seal is circular and features the department's emblem in the center. The emblem consists of a stylized caduceus, a symbol often associated with medicine and healthcare, with three lines representing the three branches of government. The text "DEPARTMENT OF HEALTH & HUMAN SERVICES USA" is arranged around the perimeter of the circle.
Public Health Service
Food and Drug Administration 10903 New Hampshire Avenue Document Control Room -WO66-G609 Silver Spring, MI) 20993-0002
Endoscopic Technologies. Inc. D/b/a Estech c/o Mr. Tamer Ibrahim Vice President, R&D/RA/QA 2603 Camino Ramon Suite 100 San Ramon. CA. 94583
SEP 2 3 2011
Re: [510(k)] K110913
Trade/Device Name: Estech cobra surgical system with thermashield accessory Regulation Number: 21 CFR 878.4400 Regulation Name: Electrosurgical cutting and coagulation device and accessories Regulatory Class: Class II Product Code: OCL Dated: September 12, 2011 Received: September 12, 2011
Dear Mr. Ibrahim:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
3
Page 2 - Mr. Tamer Ibrahim
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801). please go to http://www.fda.gov/AboutFDA/CentersOffices/CDRH/CDRHOffices/ucm115809.htm for the Center for Devices and Radiological Health's (CDRH's) Office of Compliance. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportalProblem/default.htm for the CDRH 's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/Resourcesfor You/Industry/default.htm.
Sincerely yours.
Integrity, yob,
Bram D. Zyckerman, M.D. Director Division of Cardiovascular Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
4
Image /page/4/Picture/0 description: The image shows the word "estech" in lowercase letters next to a circular logo. The logo is a circle with a textured background and three white, elongated shapes inside. The word "estech" is written in a simple, sans-serif font and is positioned to the right of the logo.
Section 4: Indications for Use
K 110943 510(k) Number (if known):
ESTECH Cobra Surgical System with ThermaShield Accessory Device Name:
Indications for Use:
The Estech Cobra Surgical System is intended for the coagulation of cardiac tissue using radiofrequency (RF) energy during cardiac surgery. The System can be used during general surgery to coagulate soft tissues. The System may also be used to coagulate blood and soft tissue to produce hemostasis.
Prescription Use X
AND/OR
Over-The-Counter Use
(Part 21 CFR 801 Subpart D)
(21 CFR 807 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
| Concurrence of CDRH, Office of Device Evaluation (ODE) | |
|---|---|
| Page 1 of 1 | |
| (Division Sign-Off) | |
| Division of Cardiovascular Devices | |
| 510(k) Number | K110913 |